This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

As I work on weaving in solutions along with the critique that I dish out, I figured it was time to share some ideas I’ve had on how the concert/ticketing industry could be disrupted. I’ve been to ...

Frontline setting accelerates potential for deep, durable responses in the treatment of liver cancers Study builds on clinical validation from one of the largest datasets in the in vivo CAR field ...

PHILADELPHIA (WPHL) — A full-service canned beverage manufacturing, packing, and distribution company will be opening its first Pennsylvania facility in Philadelphia. DrinkPAK will be the first tenant ...

Ethnohistoric and recent archaeological evidence suggest that Easter Island (Rapa Nui) was a politically decentralized society organized into small, relatively autonomous kin-based communities across ...

The first official release of the 2025-26 men's college basketball NET rankings, a ranking system utilized as a sorting tool for NCAA Tournament selection committee that factors in winning percentage, ...

You need a Mac, Xcode, and a connected AI model. Start tiny, build confidence, then expand your project. AI coding works best when you give clear, specific intent. So you want to create your own ...

Scientists have crafted a visible form of a “time crystal,” a strange phase of matter that moves in endlessly repeating patterns when illuminated. Using liquid crystals similar to those in phone ...

WASHINGTON – The granddaughter of a bracero, who waited 50 days to take her seat in Congress, Rep. Adelita Grijalva stepped to the podium on the House floor and told her colleagues, "Our democracy ...

A new kind of processor that uses microwaves can be used in future AI systems or in wireless communications, a new study shows. When you purchase through links on our site, we may earn an affiliate ...

CAMBRIDGE, Mass., Nov. 7, 2025 /PRNewswire/ -- CREATE Medicines Inc. (formerly Myeloid Therapeutics), a biotechnology company advancing in vivo immune-cell programming with mRNA-LNP therapeutics, ...

MT-302, a TROP2-targeting mRNA-LNP in vivo CAR therapy, is the first treatment of its kind to move into a frontline solid tumor trial Study builds on clinical experience from over 40 patients, one of ...